Table 4 Indicators for screening NAFLD in overweight and obese PCOS patients

BMI > 26.8 mmol/L

1.953

7.050 (2.594–19.158)

< 0.001

—

—

—

Nagelkerke R² 0.572

AC > 88.3 cm

1.455

4.286 (1.642–11.183)

0.003

—

—

—

Cox-snell R² 0.409

Triglyceride > 1.57 mmol/L

2.003

7.412 (2.661–20.642)

< 0.001

1.300

3.671 (1.010-13.348)

0.048

TC > 4.67 mmol/L

1.411

4.100 (1.584–10.614)

0.004

—

—

—

LDL-C > 3.31mmol/L

2.018

7.527 (2.047–27.674)

0.002

1.589

4.900 (1.009–23.797)

0.049

Glucose > 4.83 mmol/L

1.715

5.556 (1.992–15.498)

0.001

1.314

3.720 (1.005–13.766)

0.049

Insulin > 111.35 pmol/L

2.667

14.393 (3.128–66.223)

< 0.001

2.054

7.799 (1.339–45.443)

0.022

FT > 7.6 pg/mL

1.584

4.875 (1.827–13.005)

0.002

—

—

—

SHBG < 25 nmol/L

1.974

7.200 (2.398–21.621)

< 0.001

1.749

5.751 (1.433–23.077)

0.014